Conatus Pharmaceuticals (CNAT) Tops Q3 EPS by 3c

November 8, 2016 4:25 PM EST
Get Alerts CNAT Hot Sheet
Trade CNAT Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Conatus Pharmaceuticals (NASDAQ: CNAT) reported Q3 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Conatus Pharmaceuticals (CNAT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment